UC Davis CTSC Clinical Research Center supports COVID-19 booster trial

UC Davis Health is partnering with Pfizer on two new clinical trials to test the COVID-19 booster vaccine in healthy adults. The UC Davis CTSC Clinical Research Center (CCRC) is providing professional patient care and research services to both clinical trials. It boasts a highly qualified staff who earned the Patient Safety Innovation Award in 2021 for supporting pioneering research on COVID-19 vaccines.

Read More

  • University of California Davis, CTSA Program Hub
  • Clinical Trials
  • COVID-19 Vaccines
  • Clinical Research

University Of California Davis

CTSA Program In Action Goals
Goal 2: Engage Patients and Communities in Every Phase of the Translational Process